|
1
|
Kornblihtt AR and Gutman A: Molecular
biology of the extracellular matrix proteins. Biol Rev Camb Philos
Soc. 63:465–507. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Balanis N, Wendt MK, Schiemann BJ, Wang Z,
Schiemann WP and Carlin CR: Epithelial to mesenchymal transition
promotes breast cancer progression via a fibronectin-dependent
STAT3 signaling pathway. J Biol Chem. 288:17954–17967. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Guan JL: Role of focal adhesion kinase in
integrin signaling. Int J Biochem Cell Biol. 29:1085–1096. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z,
Zhang W, Tan S, Pandey V, Yao Y, et al: Pivotal role of reduced
let-7g expression in breast cancer invasion and metastasis. Cancer
Res. 71:6463–6474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeon M, Lee J, Nam SJ, Shin I, Lee JE and
Kim S: Induction of fibronectin by HER2 overexpression triggers
adhesion and invasion of breast cancer cells. Exp Cell Res.
333:116–126. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fernandez-Garcia B, Eiró N, Marín L,
González-Reyes S, González LO, Lamelas ML and Vizoso FJ: Expression
and prognostic significance of fibronectin and matrix
metalloproteases in breast cancer metastasis. Histopathology.
64:512–522. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bae YK, Kim A, Kim MK, Choi JE, Kang SH
and Lee SJ: Fibronectin expression in carcinoma cells correlates
with tumor aggressiveness and poor clinical outcome in patients
with invasive breast cancer. Hum Pathol. 44:2028–2037. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Woods DB and Vousden KH: Regulation of p53
function. Exp Cell Res. 264:56–66. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sugrue MM, Shin DY, Lee SW and Aaronson
SA: Wild-type p53 triggers a rapid senescence program in human
tumor cells lacking functional p53. Proc Natl Acad Sci USA.
94:9648–9653. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Royds JA and Iacopetta B: p53 and disease:
When the guardian angel fails. Cell Death Differ. 13:1017–1026.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sur S, Pagliarini R, Bunz F, Rago C, Diaz
LA Jr, Kinzler KW, Vogelstein B and Papadopoulos N: A panel of
isogenic human cancer cells suggests a therapeutic approach for
cancers with inactivated p53. Proc Natl Acad Sci USA.
106:3964–3969. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Petitjean A, Mathe E, Kato S, Ishioka C,
Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53
functional properties on TP53 mutation patterns and tumor
phenotype: Lessons from recent developments in the IARC TP53
database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Di Agostino S, Strano S, Emiliozzi V,
Zerbini V, Mottolese M, Sacchi A, Blandino G and Piaggio G: Gain of
function of mutant p53: The mutant p53/NF-Y protein complex reveals
an aberrant transcriptional mechanism of cell cycle regulation.
Cancer Cell. 10:191–202. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Abbas T, White D, Hui L, Yoshida K, Foster
DA and Bargonetti J: Inhibition of human p53 basal transcription by
down-regulation of protein kinase Cdelta. J Biol Chem.
279:9970–9977. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nam JM, Onodera Y, Bissell MJ and Park CC:
Breast cancer cells in three-dimensional culture display an
enhanced radioresponse after coordinate targeting of integrin
alpha5beta1 and fibronectin. Cancer Res. 70:5238–5248. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Huang L, Cheng HC, Isom R, Chen CS, Levine
RA and Pauli BU: Protein kinase Cepsilon mediates polymeric
fibronectin assembly on the surface of blood-borne rat breast
cancer cells to promote pulmonary metastasis. J Biol Chem.
283:7616–7627. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mitra AK, Sawada K, Tiwari P, Mui K, Gwin
K and Lengyel E: Ligand-independent activation of c-Met by
fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion
and metastasis. Oncogene. 30:1566–1576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pontiggia O, Sampayo R, Raffo D, Motter A,
Xu R, Bissell MJ, Joffé EB and Simian M: The tumor microenvironment
modulates tamoxifen resistance in breast cancer: A role for soluble
stromal factors and fibronectin through β1 integrin. Breast Cancer
Res Treat. 133:459–471. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levine AJ: p53, the cellular gatekeeper
for growth and division. Cell. 88:323–331. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Issaeva N, Bozko P, Enge M, Protopopova M,
Verhoef LG, Masucci M, Pramanik A and Selivanova G: Small molecule
RITA binds to p53, blocks p53-HDM-2 interaction and activates p53
function in tumors. Nat Med. 10:1321–1328. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Espinoza-Fonseca LM: Targeting MDM2 by the
small molecule RITA: Towards the development of new multi-target
drugs against cancer. Theor Biol Med Model. 2:382005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Enge M, Bao W, Hedström E, Jackson SP,
Moumen A and Selivanova G: MDM2-dependent downregulation of p21 and
hnRNP K provides a switch between apoptosis and growth arrest
induced by pharmacologically activated p53. Cancer Cell.
15:171–183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Grinkevich VV, Nikulenkov F, Shi Y, Enge
M, Bao W, Maljukova A, Gluch A, Kel A, Sangfelt O and Selivanova G:
Ablation of key oncogenic pathways by RITA-reactivated p53 is
required for efficient apoptosis. Cancer Cell. 15:441–453. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao CY, Grinkevich VV, Nikulenkov F, Bao
W and Selivanova G: Rescue of the apoptotic-inducing function of
mutant p53 by small molecule RITA. Cell Cycle. 9:1847–1855. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oh SJ, Jung SP, Han J, Kim S, Kim JS, Nam
SJ, Lee JE and Kim JH: Silibinin inhibits TPA-induced cell
migration and MMP-9 expression in thyroid and breast cancer cells.
Oncol Rep. 29:1343–1348. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yoon JH, Choi YJ and Lee SG: Ginsenoside
Rh1 suppresses matrix metalloproteinase-1 expression through
inhibition of activator protein-1 and mitogen-activated protein
kinase signaling pathway in human hepatocellular carcinoma cells.
Eur J Pharmacol. 679:24–33. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kikkawa U, Takai Y, Tanaka Y, Miyake R and
Nishizuka Y: Protein kinase C as a possible receptor protein of
tumor-promoting phorbol esters. J Biol Chem. 258:11442–11445.
1983.PubMed/NCBI
|
|
28
|
Robbins D, Ponville J, Morris K and Zhao
Y: Involvement of PTEN in TPA-mediated p53-activation in mouse skin
epidermal JB6 cells. FEBS Lett. 586:4108–4113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ashcroft M, Taya Y and Vousden KH: Stress
signals utilize multiple pathways to stabilize p53. Mol Cell Biol.
20:3224–3233. 2000. View Article : Google Scholar : PubMed/NCBI
|
